Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

48.66
+1.743.71%
Post-market: 48.60-0.0600-0.12%18:08 EDT
Volume:15.51M
Turnover:746.72M
Market Cap:215.23B
PE:12.16
High:48.66
Open:47.84
Low:47.56
Close:46.92
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:1.25
T/O Rate:0.49%
Dividend:1.72
Dividend Rate:3.54%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.61
PE(LYR):13.44

Loading ...

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

TIPRANKS
·
Aug 19

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

Dow Jones
·
Aug 19

Novo Nordisk Launches Dosage Study for Oral Semaglutide

MT Newswires Live
·
Aug 19

Novo Nordisk Tests Semaglutide’s Alzheimer’s Potential: What Investors Should Watch

TIPRANKS
·
Aug 19

BMO Capital Remains a Hold on Novo Nordisk (NVO)

TIPRANKS
·
Aug 18

Novo Nordisk Lawsuit Ruling Lets Some Securities Claims Move Forward

TIPRANKS
·
Aug 18

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 18

Novo Nordisk downgraded to Hold from Buy at Berenberg

TIPRANKS
·
Aug 17

Novo, LightPath, Jasper, UMAC, CCEP Trending With Analysts

TIPRANKS
·
Aug 15

Novo Nordisk Completes Key Oral Semaglutide Study in Japan: What Investors Should Watch

TIPRANKS
·
Aug 14

Novo Nordisk’s SEMA-CardioDiab Hungary Study: What Real-World Oral Semaglutide Data Could Mean for NVO Investors

TIPRANKS
·
Aug 14

Novo Nordisk A/S Series B Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Novo Nordisk (NVO) Stock Still Looks Cheap On Earnings But Faces Growth Doubts

Simply Wall St.
·
Aug 13

Novo Nordisk Might Need Deals to Strengthen Drug Pipeline

Dow Jones
·
Aug 13

Movement Alert|Novo-Nordisk A/S Falls 3.05% in Regular Trading, Berenberg Downgrades Rating to Hold and Cuts Target Price

Market Focus
·
Aug 12